Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Ligand Migration from Cluster to Support: A Crucial Factor for Catalysis by Thiolate-protected Gold Clusters.

Zhang B, Sels A, Salassa G, Pollitt S, Truttmann V, Rameshan C, Llorca J, Olszewski W, Rupprechter G, Bürgi T, Barrabés N.

ChemCatChem. 2018 Dec 7;10(23):5372-5376. doi: 10.1002/cctc.201801474. Epub 2018 Nov 26.

2.

On the mechanism of rapid metal exchange between thiolate-protected gold and gold/silver clusters: a time-resolved in situ XAFS study.

Zhang B, Safonova OV, Pollitt S, Salassa G, Sels A, Kazan R, Wang Y, Rupprechter G, Barrabés N, Bürgi T.

Phys Chem Chem Phys. 2018 Feb 14;20(7):5312-5318. doi: 10.1039/c7cp08272j.

PMID:
29406541
3.

RF1 attenuation enables efficient non-natural amino acid incorporation for production of homogeneous antibody drug conjugates.

Yin G, Stephenson HT, Yang J, Li X, Armstrong SM, Heibeck TH, Tran C, Masikat MR, Zhou S, Stafford RL, Yam AY, Lee J, Steiner AR, Gill A, Penta K, Pollitt S, Baliga R, Murray CJ, Thanos CD, McEvoy LM, Sato AK, Hallam TJ.

Sci Rep. 2017 Jun 8;7(1):3026. doi: 10.1038/s41598-017-03192-z.

4.

Actin-based growth cone motility and guidance.

Omotade OF, Pollitt SL, Zheng JQ.

Mol Cell Neurosci. 2017 Oct;84:4-10. doi: 10.1016/j.mcn.2017.03.001. Epub 2017 Mar 6. Review.

5.

Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system.

Yin G, Garces ED, Yang J, Zhang J, Tran C, Steiner AR, Roos C, Bajad S, Hudak S, Penta K, Zawada J, Pollitt S, Murray CJ.

MAbs. 2012 Mar-Apr;4(2):217-25. doi: 10.4161/mabs.4.2.19202. Epub 2012 Mar 1.

6.

Pharmacokinetics of a C5a receptor antagonist in the rat after different sites of enteral administration.

Morgan M, Bulmer AC, Woodruff TM, Proctor LM, Williams HM, Stocks SZ, Pollitt S, Taylor SM, Shiels IA.

Eur J Pharm Sci. 2008 Apr 23;33(4-5):390-8. doi: 10.1016/j.ejps.2008.01.009. Epub 2008 Feb 2.

PMID:
18337070
7.

Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration.

Woodruff TM, Crane JW, Proctor LM, Buller KM, Shek AB, de Vos K, Pollitt S, Williams HM, Shiels IA, Monk PN, Taylor SM.

FASEB J. 2006 Jul;20(9):1407-17.

PMID:
16816116
8.

Increased potency of a novel complement factor 5a receptor antagonist in a rat model of inflammatory bowel disease.

Woodruff TM, Pollitt S, Proctor LM, Stocks SZ, Manthey HD, Williams HM, Mahadevan IB, Shiels IA, Taylor SM.

J Pharmacol Exp Ther. 2005 Aug;314(2):811-7. Epub 2005 May 5.

PMID:
15879003
9.

Protective effect of a human C5a receptor antagonist against hepatic ischaemia-reperfusion injury in rats.

Arumugam TV, Woodruff TM, Stocks SZ, Proctor LM, Pollitt S, Shiels IA, Reid RC, Fairlie DP, Taylor SM.

J Hepatol. 2004 Jun;40(6):934-41.

PMID:
15158333
10.

A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor.

Pollitt SK, Pallos J, Shao J, Desai UA, Ma AA, Thompson LM, Marsh JL, Diamond MI.

Neuron. 2003 Nov 13;40(4):685-94.

11.
12.

Genetic mapping of the human C5a receptor. Identification of transmembrane amino acids critical for receptor function.

Geva A, Lassere TB, Lichtarge O, Pollitt SK, Baranski TJ.

J Biol Chem. 2000 Nov 10;275(45):35393-401.

13.

Localization of a peripheral membrane protein: Gbetagamma targets Galpha(Z).

Fishburn CS, Pollitt SK, Bourne HR.

Proc Natl Acad Sci U S A. 2000 Feb 1;97(3):1085-90.

14.

Decreased glucose metabolism causes separation of hoof lamellae in vitro: a trigger for laminitis?

Pass MA, Pollitt S, Pollitt CC.

Equine Vet J Suppl. 1998 Sep;(26):133-8.

PMID:
9932104
15.

Batimastat (BB-94) inhibits matrix metalloproteinases of equine laminitis.

Pollitt CC, Pass MA, Pollitt S.

Equine Vet J Suppl. 1998 Sep;(26):119-24.

PMID:
9932102
16.

A Photochemical Switch for Controlling Protein-Protein Interactions.

Pollitt SK, Schultz PG.

Angew Chem Int Ed Engl. 1998 Aug 17;37(15):2104-2107. doi: 10.1002/(SICI)1521-3773(19980817)37:15<2104::AID-ANIE2104>3.0.CO;2-Z.

PMID:
29711048
18.

Effect of OmpA signal peptide mutations on OmpA secretion, synthesis, and assembly.

Tanji Y, Gennity J, Pollitt S, Inouye M.

J Bacteriol. 1991 Mar;173(6):1997-2005.

20.
21.
22.

A relationship between hepatic metabolism of reduced lantadene A and its toxicity in rats and sheep.

Pass MA, Goosem MW, Pollitt S.

Comp Biochem Physiol C. 1985;82(2):457-61.

PMID:
2866921
23.

Supplemental Content

Loading ...
Support Center